US Broker Ratings

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Unpacking its 6.02% Upside Potential

Investors seeking opportunities in the healthcare sector might find Zimmer Biomet Holdings, Inc. (NYSE: ZBH) an intriguing option. With a market capitalization of $18.01 billion, this U.S.-based medical device company..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Healthcare Giant with 39.78% Upside Potential

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading player in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors looking to capitalize on the growing..

Alcon Inc. (ALC) Stock Analysis: A Healthcare Giant with a 29.68% Upside Potential

For investors with an eye on the healthcare sector, Alcon Inc. (ALC) presents a compelling opportunity. Headquartered in Geneva, Switzerland, Alcon is a leader in the medical instruments and supplies..

Amgen Inc. (AMGN)

⚠️ No article content returned.

..

The Cigna Group (CI) Stock Analysis: Exploring a 20% Potential Upside for Investors

The Cigna Group (NYSE: CI), a prominent player in the healthcare sector, stands as a compelling choice for investors seeking both stability and growth potential in their portfolios. As of..

argenx SE (ARGX) Stock Analysis: An Upside of 17.57% Awaits Investors in Biotech Powerhouse

argenx SE (NASDAQ: ARGX), a leading player in the biotechnology sector, has garnered significant attention from investors thanks to its robust growth metrics and promising product pipeline. Headquartered in Amsterdam,..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Growth Prospects Amid a 1.35% Potential Upside

Merck & Company, Inc. (NYSE: MRK) stands as a formidable player in the healthcare sector, with a market capitalization of $317.77 billion. Based in the United States, Merck operates globally,..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with 11.67% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to capture the attention of investors in the biotechnology sector. With a current market cap of $124.7 billion, Vertex stands as a significant player..

Agilent Technologies, Inc. (A) Stock Analysis: Unpacking a 17.88% Potential Upside for Investors

Agilent Technologies, Inc. (NYSE: A), a pivotal player in the Healthcare sector, stands out in the Diagnostics & Research industry with a commendable market capitalization of $38.41 billion. As the..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 29% Upside with a Robust Dividend Yield

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the global healthcare sector, commands attention with its rich history dating back to 1781. Headquartered in Chuo, Japan, Takeda has carved..

Stryker Corporation (SYK) Stock Analysis: Exploring a 16.26% Potential Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a significant market capitalization of $127.55 billion, Stryker is a..

Thermo Fisher Scientific Inc (TMO)

⚠️ No article content returned.

..

Eli Lilly (LLY) Stock Analysis: A Trillion-Dollar Giant with Robust Revenue Growth and Strong Buy Ratings

Eli Lilly and Company (NYSE: LLY) stands tall as a formidable player in the healthcare sector, specifically within the drug manufacturers industry. With a staggering market capitalization of $1.08 trillion,..

Cencora, Inc. (COR) Stock Analysis: Evaluating the 22.67% Upside Potential in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a prominent player in the medical distribution industry, presents a compelling investment opportunity for those eyeing the healthcare sector. Formerly known as AmerisourceBergen Corporation, Cencora has..

Pfizer, Inc. (PFE) Stock Analysis: Exploring a Potential 20% Upside Amidst Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE) remains a prominent player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $138.44 billion, the company is a heavyweight..

AbbVie Inc. (ABBV) Stock Analysis: Navigating a $447.62 Billion Market Cap with Solid Growth and Dividends

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its robust market cap of $447.62 billion. As a research-based biopharmaceutical company, AbbVie engages..

Abbott Laboratories (ABT) Stock Analysis: Potential 23.82% Upside Amid Strong Buy Ratings

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, remains a compelling investment opportunity for individual investors seeking exposure to the dynamic medical devices industry. With a commanding market..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring the 111.90% Potential Upside for Investors

Investors seeking opportunities in the biotech sector might want to turn their attention to Vaxcyte, Inc. (PCVX), a clinical-stage vaccine innovation company that is making strides in the prevention and..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Navigating the Biotech Sector with a Strong Free Cash Flow

Soleno Therapeutics, Inc. (SLNO), a biopharmaceutical company specializing in the development of novel therapeutics for rare diseases, has been capturing investor interest despite a neutral stock performance outlook. With a..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a 70.98% Potential Upside for Astute Investors

Investors have their eyes set on iRhythm Holdings, Inc. (IRTC), as the digital healthcare company continues to serve as a pivotal player in the medical devices industry. Specializing in ambulatory..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds